Lattice Biologics Ltd V.LBL.H

Alternate Symbol(s): LBLTF

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > LBL currently testing this in three countries to get result

<< Previous

Bullboard Posts

Next >>

Post by colimaon Apr 23, 2020 12:14pm

163 Views

Post# 30945100

LBL currently testing this in three countries to get result

Does LBL have enough employees for all this testing ? Is the testing being conducted by other labs under contract with LBL? Who are the other two countries where tests are currently being conducted ? I believe LBL is a very small company with not too many employees. And CURRENTLY TESTING in THREE COUNTRIES . HOW ?

<< Previous

Bullboard Posts

Next >>

dynaCERT leans into global growth with new HydraGEN orders